ArticleCancers2023

Bevacizumab versus Ramucirumab in EGFR-Mutated Metastatic Non-Small-Cell Lung Cancer Patients: A Real-World Observational Study.

Wen-Chien Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.